Challenges in mitigating weight regain with incretin-based therapy
André J Scheen
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00871-8/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_eco26&_hsenc=p2ANqtz--So9cmK_nvdpEq1ULXZ-MzaZSgimSREwmAhccCnycdqSVD92HRgmSuZpOhc3nKX-p_BZmtSovz33gFFbzC4LylAtsJmQ&_hsmi=418914030&utm_content=418914030&utm_source=hs_email
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial
Prof Deborah B Horn, DOa ∙ Prof Louis J Aronne, MDb ∙ Prof Sean Wharton, MDc,d ∙ Prof Harold E Bays, MDe ∙ Prof Carel W le Roux, MDf ∙ Prof Reshmi Srinath, MDg ∙ et al.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00656-2/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_eco26&_hsenc=p2ANqtz-8ONtqMN18ijR0Eduo9G6fM0NlCclIn2vT1B7iD4jANFOwlD9WBvSTNJ6uCR59ESxEsCiHOZOJiplq8qExbCkmr1yeBkw&_hsmi=418914030&utm_content=418914030&utm_source=hs_email
No hay comentarios:
Publicar un comentario